Orris

What is acid base status of ckd

Reading File
Quick Answer: CKD classically causes metabolic acidosis - specifically a normal anion gap (hyperchloremic) acidosis in early stages, shifting to a high anion gap acidosis in advanced stages (GFR <20-15 mL/min). The primary defect is impaired renal acid excretion (reduced NH4+ production) and loss of bicarbonate-generating capacity.
Searching sources...
Finding Sources
Searching PubMed

metabolic acidosis chronic kidney disease

Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have excellent, comprehensive textbook content from Harrison's 22E and Goldman-Cecil Medicine. Here is the full answer:

Acid-Base Status in Chronic Kidney Disease (CKD)

Primary Disturbance: Metabolic Acidosis

CKD causes metabolic acidosis as the kidney progressively loses its ability to excrete the net acid load (~1 mEq/kg/day) generated from protein metabolism and endogenous acid production.

Anion Gap Pattern by CKD Stage

This is the most important clinical concept - the type of metabolic acidosis evolves with disease progression:
CKD StageGFR (mL/min/1.73m²)Acid-Base PatternMechanism
Stage 3 (Mild-Moderate)30-59Normal Anion Gap (Hyperchloremic) Metabolic AcidosisReduced NH4+ production/excretion; HCO3- falls, Cl- rises reciprocally
Stage 3B-415-30Transitional / MixedBoth mechanisms contributing
Stage 4-5 (Advanced/ESRD)<15-20High Anion Gap (Uremic) Metabolic AcidosisRetention of unmeasured anions: sulfate, phosphate, urate, hippurate, oxalate
As Harrison's 22E states directly:
"The hyperchloremic acidosis of moderate CKD (stage 3B) is eventually converted to the high-AG acidosis of advanced renal failure (stages 4 and 5 CKD)."

Pathogenesis

1. Reduced NH4+ (Ammonium) Production and Excretion
  • This is the primary defect in CKD
  • As nephron mass decreases, the remaining nephrons cannot synthesize sufficient NH3 (ammonia) in the proximal tubule
  • NH4+ is the major vehicle for urinary acid excretion - when it fails, H+ accumulates
  • In advanced CKD, the rate of NH4+ production and excretion is markedly reduced
2. Accumulation of Unmeasured Anions (Advanced CKD)
  • As GFR falls to <20 mL/min, filtered organic anions are poorly excreted
  • Sulfate, phosphate, urate, hippurate, hydroxypropionate, furanpropionate, and oxalate accumulate
  • These raise the anion gap: AG = Na+ - (Cl- + HCO3-)
3. Bone Buffering
  • Despite retaining up to 20 mmol/day of acid, serum HCO3- often stabilizes (typically 12-20 mEq/L) because bone carbonate salts act as buffers
  • The trade-off: progressive renal osteodystrophy (loss of bone calcium carbonate), worsening osteomalacia and osteoporosis

Serum Bicarbonate Level

  • Typically falls to 12-20 mEq/L in moderate-to-advanced CKD
  • Does NOT typically fall below 12 mEq/L unless there is a superimposed acute acidosis - bone buffers prevent this
  • Target for therapy: maintain HCO3- > 22-24 mmol/L

Respiratory Compensation

  • Secondary hyperventilation (Kussmaul breathing in severe cases)
  • Expected compensation: PCO2 = 1.5 × [HCO3-] + 8 ± 2 (Winter's formula)
  • e.g., if HCO3- = 16, expected PCO2 ≈ 32 mmHg

Consequences of Chronic Metabolic Acidosis in CKD

These are clinically important and independent reasons to treat:
  1. Muscle catabolism and wasting - acid activates the ubiquitin-proteasome pathway
  2. Bone disease - bone carbonate depletion worsens renal osteodystrophy
  3. CKD progression - high-AG acidosis in advanced CKD independently accelerates the progressive loss of kidney function
  4. Hyperkalemia - acidosis shifts K+ out of cells
  5. Hormonal effects - reduces growth hormone and IGF-1 signaling

Treatment

  • Oral alkali supplementation (1.0-1.5 mmol/kg/day) to maintain serum HCO3- >22-24 mmol/L
    • Sodium bicarbonate tablets (650 mg = 7.8 mEq) or sodium citrate (Shohl's solution)
  • Dietary modification: increasing fruits and vegetables (citrate-rich) raises plasma HCO3- and slows CKD progression safely - hyperkalemia is not a common complication of this approach
  • Alkali therapy has been shown to slow the progression of CKD

Summary Table

ParameterFinding in CKD
Primary disturbanceMetabolic acidosis
Anion gap (early, stage 3)Normal (hyperchloremic)
Anion gap (late, stage 4-5)High (uremic, >12 mEq/L)
Serum HCO3-Typically 12-20 mEq/L
Serum Cl- (early)Elevated (reciprocal to HCO3-)
NH4+ excretionReduced
Respiratory responseCompensatory hyperventilation (low PCO2)
Urine pHVariable (not reliably acidic due to low NH4+)
Sources: Harrison's Principles of Internal Medicine 22E (2025), p. 415; Goldman-Cecil Medicine, p. 1225; Comprehensive Clinical Nephrology, 7th Ed.
Recent evidence note: Two 2024 reviews (PMID 38279993 and 39514096) highlight that metabolic acidosis in CKD is not merely a consequence but may actively drive further kidney injury - reinforcing aggressive alkali therapy targets consistent with the above textbook guidance.
This is a shared conversation. Sign in to Orris to start your own chat.